Companies / CTE

CRYOSITE LIMITED

ASX:CTEPharmaceuticals, Biotechnology & Life Sciences
48.8M shares on issueASX (delayed) · as of 28 July 2026$1.20price · delayed$58.6Mmarket cap · indicative
A
Dilution grade

No issuance filings since 2024; no dilution pressure signals in current disclosures

Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)0.0%no issuance filings since 2024
Raise cadence (24m)0 cash raises
Options & rights overhang0.0% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

CRYOSITE LIMITED listed in May 2002 and its disclosure history spans back to that date. There are no share-issuance (Appendix 2A) filings on record in the window and no new share-issuance (Appendix 2A) filings lodged since January 2024. The company did not raise capital in the 24-month window reported. The company does not have a current quarterly cash report on record, so no quarterly cash balance or funding-runway figure is disclosed. There are no proposed securities issues (Appendix 3B) currently pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
0.0%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 48.8M per ASX (delayed) (28 July 2026).
48.6M48.8M49.0MDec 24Sept 25July 26

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 3 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
18 Mar 20263G · unquotedORDINARY FULLY PAID48.8MAppendix 3G
23 Oct 20253G · unquotedCTE : ORDINARY FULLY PAID48.8MAppendix 3G
17 Mar 20253G · unquotedCTE : ORDINARY FULLY PAID48.8MAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

No options or rights over unissued shares on record.

Director dealings

DateDirectorTypeSharesOptionsValueSource
27 June 2025Mark KerrBuy753Y notice
4 Apr 2025Mark KerrBuy231k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.